MINT PROJECT Competitors

For 15 years, Omada Health has been in the corner of millions of Americans managing chronic conditions. We help our members between doctor visits, providing virtual care that adapts to real life. We partner with employers, health plans, pharmacy benefit managers, and government agencies to support their populations across common chronic conditions — from prediabetes, diabetes, and hypertension to muscle and joint pain— all through the convenience of an app. Our programs also adapt to provide specialized care for GLP-1 journeys. At Omada, care isn’t built for perfection. It’s built for real people. Our clinically-validated programs combine human connection with modern technology, pairing members with real coaches and care teams. Omada’s impact is proven: our outcomes are published in 30 peer-reviewed studies, showing lasting behavior change, reduced healthcare costs, and ROI for our partners. Our success starts with our people. Omada’s strong, inclusive culture has earned us the Great Place to Work certification, and in 2025 we became a Nasdaq-listed company — a milestone on our mission to bend the curve of chronic disease.

LifeScan is a global leader in blood glucose monitoring innovation and digital health technology and has a vision to create a world without limits for people with diabetes and related conditions. More than 20 million people and their caregivers around the world count on LifeScan’s OneTouch brand products to manage their diabetes. Together, LifeScan and OneTouch improve the quality of life for people with diabetes with products and digital platforms defined by simplicity, accuracy, and trust.

Glooko is a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum. We’re uniquely positioned to be the enterprise partner of choice for healthcare providers seeking to reduce glycemic risk, improve safety, and support overburdened clinical teams with coordinated expertise across both outpatient and inpatient care settings. Our connected care solutions portfolio includes the outpatient Glooko diabetes management platform, Glooko Mobile App for people with diabetes, inpatient EndoTool Glucose Management System, and the Glooko XT remote patient monitoring platform in France.